>>Signaling Pathways>> DNA Damage/DNA Repair>> DNA/RNA Synthesis>>Dehydroaltenusin

Dehydroaltenusin

Catalog No.GC35829

Dehydroaltenusin은 IC50 값이 0.68μM인 곰팡이에 의해 생성되는 항생제 유형인 진핵생물 DNA 중합효소 α의 소분자 선택적 억제제입니다. 포유류 pol α 활성에 대한 dehydroaltenusin의 억제 작용 방식은 DNA 주형 프라이머(Ki=0.23μM)와 관련하여 경쟁적이며 2'-deoxyribonucleoside 5'-triphosphate 기질(Ki=0.18μM)과 관련하여 비경쟁적입니다. . Dehydroaltenusin은 S기에서 암세포 주기를 정지시키고 세포자멸사를 유발합니다. Dehydroaltenusin은 생체 내에서 인간 선암종 종양에 대한 항종양 활성을 가지고 있습니다.

Products are for research use only. Not for human use. We do not sell to patients.

Dehydroaltenusin Chemical Structure

Cas No.: 31186-13-7

Size 가격 재고 수량
100mg Please Inquire Please Inquire
250mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Dehydroaltenusin is a small molecule selective inhibitor of eukaryotic DNA polymerase α, a type of antibiotic produced by a fungus with an IC50 value of 0.68 μM. The inhibitory mode of action of dehydroaltenusin against mammalian pol α activity is competitive with respect to the DNA template primer (Ki=0.23 µM) and non-competitive with respect to the 2'-deoxyribonucleoside 5'-triphosphate substrate (Ki=0.18 µM)[1].Dehydroaltenusin arrests the cancer cell cycle at the S-phase and triggers apoptosis[1].Dehydroaltenusin possesses anti-tumor activity against human adenocarcinoma tumor in vivo[1]. IC50: 0.68 μM (DNA polymerase α)[1]

Dehydroaltenusin (38.0-44.4 μM; 24 hours) inhibits cell growth in a dose-dependent manner and the LD50 values varies from 38.0 to 44.4 μM[1].Dehydroaltenusin (38.0 μM; 6 hours) inhibits cell growth by blocking the S-phase of DNA replication[1].Dehydroaltenusin (75.0 μM; 24 hours) has a strong apoptotic effect on human cancer cells, DNA ladders can be detected after 12 h of incubation with dehydroaltenusin[1]. Cell Proliferation Assay[1] Cell Line: Human cancer cell line: A549, BALL-1, HeLa and NUGC-3 cells

Dehydroaltenusin (injection; 20 mg/kg; 2-day intervals; 12-39 days) shows suppressed tumor growth from 21 days[1]. Animal Model: Nude mice bearing HeLa solid tumors[1]

[1]. Mizushina Y, et al. Dehydroaltenusin is a specific inhibitor of mammalian DNA polymerase α. Expert Opin Investig Drugs. 2011 Nov;20(11):1523-34.

리뷰

Review for Dehydroaltenusin

Average Rating: 5 ★★★★★ (Based on Reviews and 33 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Dehydroaltenusin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.